Joseph Nacson

Joseph Nacson is a highly experienced medical professional with a strong background in oncology and clinical development. Currently serving as Senior Global Development Medical Director at AstraZeneca since July 2024, Joseph previously held the position of Medical Director for Clinical Development at Exelixis from September 2023 to July 2024. Before that, Joseph was a Clinical Trial Physician and WW Medical Lead for Early Assets & Biomarkers at Bristol Myers Squibb from May 2020 to September 2023. Joseph's academic credentials include a Ph.D. in Oncology and Cancer Biology from Temple University's Lewis Katz School of Medicine, as well as specialized training in breast surgery. Joseph's extensive experience also encompasses roles at Fox Chase Cancer Center, Hospital Pérola Byington, and Massachusetts General Hospital, contributing significantly to cancer research and clinical practice.